Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · IEX Real-Time Price · USD
1.380
+0.060 (4.55%)
May 31, 2024, 4:00 PM EDT - Market closed
Perspective Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for CATX stock have an average target of 2.10, with a low estimate of 1.50 and a high estimate of 3.00. The average target predicts an increase of 52.17% from the current stock price of 1.38.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CATX stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 3 | 3 | 3 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jones Trading | Jones Trading | Strong Buy Maintains $1.5 → $2.2 | Strong Buy | Maintains | $1.5 → $2.2 | +59.42% | May 16, 2024 |
| RBC Capital | RBC Capital | Buy Initiates $3 | Buy | Initiates | $3 | +117.39% | May 14, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | May 9, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $1.2 → $1.7 | Strong Buy | Maintains | $1.2 → $1.7 | +23.19% | Apr 9, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $1.2 → $1.5 | Buy | Reiterates | $1.2 → $1.5 | +8.70% | Apr 1, 2024 |
Financial Forecast
Revenue This Year
523.26K
from 1.43M
Decreased by -63.51%
Revenue Next Year
406.22K
from 523.26K
Decreased by -22.37%
EPS This Year
-0.10
from -0.17
EPS Next Year
-0.11
from -0.10
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 1.4M | 1.5M | 1.5M | 14.8M |
| Avg | 523,260 | 406,215 | 571,537 | 14.4M |
| Low | 294,000 | n/a | n/a | 13.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -1.9% | 179.6% | 274.4% | 2,494.2% |
| Avg | -63.5% | -22.4% | 40.7% | 2,420.0% |
| Low | -79.5% | - | - | 2,321.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.07 | -0.07 | -0.08 |
| Avg | -0.10 | -0.11 | -0.11 |
| Low | -0.12 | -0.14 | -0.14 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.